REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Pharma & Healthcare

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

1 2 3 4 5 6
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
Malaysia Pharma and Healthcare Sector Report 2019-2020 - Page 1
Malaysia Pharma and Healthcare Sector Report 2019-2020 EMIS Insights Industry Reports

Malaysia has one of the most developed pharmaceuticals and healthcare sectors in the ASEAN region. The country operates a dual public-private healthcare system in which the government, under the Ministry of Health (“MoH”), both regulates ...

View more details
USD 495 Date: January 2020 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2019 3rd Quarter - Page 1
China Healthcare Sector Report 2019 3rd Quarter EMIS Insights Industry Reports

China’s healthcare sector kept growing over the second quarter of 2019. The period was characterised by increased government spending on healthcare, with the amount dedicated to health and family planning rising by 5.9% y/y to RMB 534.5bn in Q2 ...

View more details
USD 495 Date: November 2019 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2019 2nd Quarter - Page 1
China Healthcare Sector Report 2019 2nd Quarter EMIS Insights Industry Reports

The first quarter of 2019 witnessed a continuous growth of China’s healthcare sector. The country promoted the implementation of the Healthy China Initiative, as well as ongoing structural reforms in the sector. The period was characterized by ...

View more details
USD 495 Date: August 2019 Language: English
Format: PDF
Add to basket
Hungary Pharma and Healthcare Sector Report 2019/2020 - Page 1
Hungary Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

The changing demographic and disease profiles of Hungary were the drivers of the expansion of health expenditure in recent years. As a result, the country spent 7.4% of its GDP on healthcare in 2016, still below the EU average. The government ...

View more details
USD 495 Date: August 2019 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2019 1st Quarter - Page 1
China Healthcare Sector Report 2019 1st Quarter EMIS Insights Industry Reports

China’s healthcare sector continued to grow in Q4 2018, largely stimulated by the expansion of online healthcare services. The growth was attributed to increasing demand for quality healthcare, driven by the country’s strong economic ...

View more details
USD 495 Date: June 2019 Language: English
Format: PDF
Add to basket
1 2 3 4 5 6